ReviewInternational journal of women's health2026
Acupuncture in Polycystic Ovary Syndrome: A Narrative Review of Neuroendocrine-Immune Evidence, Reproductive Outcomes, and Evidence Gaps.
Review in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous reproductive, endocrine, and metabolic disorder in which autonomic, neuroendocrine, inflammatory, and metabolic abnormalities may converge on ovarian and endometrial function. This narrative review evaluates evidence relevant to acupuncture in PCOS, with emphasis on evidence source, directness, and clinically meaningful reproductive outcomes. PubMed, Embase, and Web of Science were searched from inception to March 31, 2026, supplemented by backward citation tracking. We prioritized human PCOS trials and mechanistic studies, followed by PCOS-specific preclinical evidence; findings from other conditions were included only as explicitly labeled indirect evidence. No formal risk-of-bias assessment or meta-analysis was undertaken. Clinical evidence most consistently suggests possible effects on menstrual or ovulatory function, sympathetic activity, and insulin resistance, although results vary across protocols and PCOS phenotypes. Evidence for pregnancy, ongoing pregnancy, embryo quality, and live birth remains limited and inconsistent, and acupuncture has not been established as a substitute for guideline-based fertility treatment. Human data directly linking acupuncture to immune-cell reprogramming, endometrial immune tolerance, or correction of window-of-implantation timing are scarce. PCOS-specific animal studies provide plausible signals involving hypothalamic-pituitary-ovarian regulation, ovarian sympathetic signaling, inflammatory pathways, oxidative stress, and insulin signaling, but these findings cannot be assumed to translate to clinical reproductive benefit. Overall, the neuroendocrine-immune framework is best viewed as a hypothesis-guiding map that distinguishes relatively supported clinical domains from preclinical and indirect mechanisms. Future trials should combine standardized acupuncture protocols with phenotype stratification, prespecified ovulation, ongoing-pregnancy, and live-birth outcomes, and longitudinal autonomic, metabolic, inflammatory, ovarian, and endometrial measurements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.